Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-24 @ 9:57 PM
NCT ID:
NCT01394432
Eligibility Criteria:
Inclusion Criteria:
* Patients with acute Q-wave myocardial infarction after thrombolitic therapy during 6-36 hours from the onsent of signs
* Oclusion or significant stenosis of infarct-related left anterior descending artery (LAD)
* Left ventricle ejection fraction (LVEF) \< 50% measured by Echo
Exclusion Criteria:
* Thrombolysis of pyrrolase or streptokinase
* Surgical unsignificant stenosis of LAD
* Indications for CABG
* Cardiogenic shock
* Uncontrolled hypertension
* Thrombocytopenia
* Ongoing bleeding
* Anemia \< 100 g/l
* Oncology
* Patients, who required anticoagulation therapy at the time of inclusion
* Obesity, BMI\>40
* Severe comorbidities
* Unwillingness to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
75 Years
Study:
NCT01394432
Study Brief:
Protocol Section:
NCT01394432